Home > Insider Trading > Filing (0001209191-16-110214)

Filing Details

Accession Number:: 0001209191-16-110214
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2016-03-23 16:24:14
Reporting Period:: 2015-11-16

Filing Date:: 2016-03-23
Accepted Time:: 2016-03-23 16:24:14
Original Submission Date:: 2016-03-23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1439222	Agios Pharmaceuticals Inc	AGIO	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1581950	Jr. Clayton Lewis Cantley	C/O Agios Pharmaceuticals, Inc. 88 Sidney Street Cambridge MA 02139		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-11-16	1,362	$59.59	141,640	No	4	S	Direct
Common Stock	Disposition	2015-11-16	1,360	$59.58	141,642	No	4	S	Indirect	See footnote
Common Stock	Disposition	2015-11-17	3,490	$59.99	138,150	No	4	S	Direct
Common Stock	Disposition	2015-11-17	3,492	$59.98	138,150	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Indirect	See footnote
No	4	S	Direct
No	4	S	Indirect	See footnote

Footnotes

This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $58.21 to $61.78. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
This form 4 is amended to include the sale of 149 and 147 shares of the Company's common stock by the reporting person and the reporting person's spouse, respectively, on November 16, 2015. The sale of these shares was also not reflected in the securities beneficially owned by the reporting person and the reporting person's spouse on the three subsequent forms 4 filed by the reporting person.
Shares held by Vicki Lee Sato, who is the reporting person's spouse.
The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $59.24 to $61.52. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $59.23 to $61.76. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.